Search - tctmd.com

Displaying 741 - 760 of 962

Sort: Relevancy | Date

News Daily News

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Michael O'Riordan

December 02, 2015

News Daily News

Observational Study Hints at Real Benefits for Patients Who Take PUFAs After Acute MI

November 30, 2015

News Daily News

TATORT-NSTEMI: Still No Role for Thrombus Aspiration in NSTEMI

Shelley Wood

November 19, 2015

News Daily News

Study Suggests Nonculprit Revascularization Enhances Health Status of STEMI Patients

Todd Neale

November 04, 2015

News Daily News

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

L.A. McKeown

November 01, 2015

News Daily News

Morphine’s Worrisome Effects on Ticagrelor Affirmed in Pharmacokinetic Study

Shelley Wood

October 29, 2015

News Daily News

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Todd Neale

October 26, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Conference News TCT 2015

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Nicole Lou

October 13, 2015

News Conference News TCT 2015

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

October 13, 2015

News Industry News

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

October 13, 2015

News Daily News

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

Todd Neale

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Industry News

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

October 13, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Yael L. Maxwell

September 02, 2015

Advertisement

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Observational Study Hints at Real Benefits for Patients Who Take PUFAs After Acute MI

TATORT-NSTEMI: Still No Role for Thrombus Aspiration in NSTEMI

Study Suggests Nonculprit Revascularization Enhances Health Status of STEMI Patients

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

Morphine’s Worrisome Effects on Ticagrelor Affirmed in Pharmacokinetic Study

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

Discussion Highlights Merits, Limitations of Small Trials

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

Novel Devices Present New Treatment Options for STEMI

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content